Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China · Delayed Price · Currency is CNY 49.00
+0.94 (1.96%)
Jul 18, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
Anesthetic Products | 1.23B | Log In | Log In | Log In | Log In | Upgrade |
Anesthetic Products Growth | 44.96% | Log In | Log In | Log In | Log In | Upgrade |
Cooperative Products | 943.17M | Log In | Log In | Log In | Log In | Upgrade |
Other Indications | 580.47M | Log In | Log In | Log In | Log In | Upgrade |
Parenteral Nutrition System | 511.93M | Log In | Log In | Log In | Log In | Upgrade |
Parenteral Nutrition System Growth | -16.79% | Log In | Log In | Log In | Log In | Upgrade |
Antiemetic for Tumors | 305.42M | Log In | Log In | Log In | Log In | Upgrade |
Antiemetic for Tumors Growth | 44.26% | Log In | Log In | Log In | Log In | Upgrade |
Other Main Business | 120.10M | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 28.60M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | 43.48% | Log In | Log In | Log In | Log In | Upgrade |
Raw Materials | - | Log In | Log In | Log In | Log In | Upgrade |
Services | - | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics | - | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular | - | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular and Cerebrovascular Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Hepatobiliary Digestion | - | Log In | Log In | Log In | Log In | Upgrade |
Hepatobiliary Digestion Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
APIs and Patented Technology | - | Log In | Log In | Log In | Log In | Upgrade |
APIs and Patented Technology Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Marketing | - | Log In | Log In | Log In | Log In | Upgrade |
Marketing Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2008 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2008 - 2019 |
China | 3.72B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 10.92% | Log In | Log In | Log In | Log In | Upgrade |